137 related articles for article (PubMed ID: 28959317)
1. The Effects of Organic Solvents on the Physicochemical Properties of Human Serum Albumin Nanoparticles.
Mohammad-Beigi H; Shojaosadati SA; Morshedi D; Mirzazadeh N; Arpanaei A
Iran J Biotechnol; 2016 Mar; 14(1):45-50. PubMed ID: 28959317
[TBL] [Abstract][Full Text] [Related]
2. Albumin nanoparticles with predictable size by desolvation procedure.
Storp Bv; Engel A; Boeker A; Ploeger M; Langer K
J Microencapsul; 2012; 29(2):138-46. PubMed ID: 22329480
[TBL] [Abstract][Full Text] [Related]
3. Effects of Desolvating Agent Types, Ratios, and Temperature on Size and Nanostructure of Nanoparticles from α-Lactalbumin and Ovalbumin.
Etorki AM; Gao M; Sadeghi R; Maldonado-Mejia LF; Kokini JL
J Food Sci; 2016 Oct; 81(10):E2511-E2520. PubMed ID: 27636231
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of rivastigmine loaded human serum albumin (HSA) nanoparticles.
Avachat AM; Oswal YM; Gujar KN; Shah RD
Curr Drug Deliv; 2014; 11(3):359-70. PubMed ID: 24893995
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea-Loaded Albumin Nanoparticles: Preparation, Characterization, and In Vitro Studies.
Tazhbayev Y; Mukashev O; Burkeev M; Kreuter J
Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31409024
[TBL] [Abstract][Full Text] [Related]
7. Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization.
Lomis N; Westfall S; Farahdel L; Malhotra M; Shum-Tim D; Prakash S
Nanomaterials (Basel); 2016 Jun; 6(6):. PubMed ID: 28335244
[TBL] [Abstract][Full Text] [Related]
8. Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
Langer K; Balthasar S; Vogel V; Dinauer N; von Briesen H; Schubert D
Int J Pharm; 2003 May; 257(1-2):169-80. PubMed ID: 12711172
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation.
Qu N; Sun Y; Li Y; Hao F; Qiu P; Teng L; Xie J; Gao Y
Biomed Eng Online; 2019 Jan; 18(1):11. PubMed ID: 30704488
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
[TBL] [Abstract][Full Text] [Related]
11. A comparative and systematic approach to desolvation and self-assembly methods for synthesis of piperine-loaded human serum albumin nanoparticles.
Abolhassani H; Shojaosadati SA
Colloids Surf B Biointerfaces; 2019 Dec; 184():110534. PubMed ID: 31627104
[TBL] [Abstract][Full Text] [Related]
12. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
[TBL] [Abstract][Full Text] [Related]
13. The interplay of solvent-drug-protein interactions during albumin nanoparticles formulations for temozolomide delivery to brain cancer cells.
Helal DO; Abdel-Mottaleb MMA; Kamel AO; Rouatbi N; Han S; Geneidi AS; Al-Jamal KT; Awad GAS
J Pharm Pharmacol; 2023 Jul; 75(7):921-930. PubMed ID: 37279781
[TBL] [Abstract][Full Text] [Related]
14. Pullulan-Based Nanoparticle-HSA Complex Formation and Drug Release Influenced by Surface Charge.
Yuan L; Cao Y; Luo Q; Yang W; Wu X; Yang X; Wu D; Tan S; Qin G; Zhou J; Zeng Y; Chen X; Tao X; Zhang Q
Nanoscale Res Lett; 2018 Oct; 13(1):317. PubMed ID: 30306404
[TBL] [Abstract][Full Text] [Related]
15. Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.
Esfandyari-Manesh M; Mostafavi SH; Majidi RF; Koopaei MN; Ravari NS; Amini M; Darvishi B; Ostad SN; Atyabi F; Dinarvand R
Daru; 2015 Apr; 23(1):28. PubMed ID: 25903677
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Multispectroscopic Analysis on the Interaction and Corona Formation of Human Serum Albumin with Gold/Silver Alloy Nanoparticles.
Selva Sharma A; Ilanchelian M
J Phys Chem B; 2015 Jul; 119(30):9461-76. PubMed ID: 26106942
[TBL] [Abstract][Full Text] [Related]
17. Maghemite-human serum albumin hybrid nanoparticles: towards a theranostic system with high MRI r
Ishay RB; Israel LL; Eitan EL; Partouche DM; Lellouche JP
J Mater Chem B; 2016 Jun; 4(21):3801-3814. PubMed ID: 32263318
[TBL] [Abstract][Full Text] [Related]
18. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.
Kim H; Robinson SB; Csaky KG
Pharm Res; 2009 Feb; 26(2):329-37. PubMed ID: 18958405
[TBL] [Abstract][Full Text] [Related]
19. Titanium dioxide nanoparticles preferentially bind in subdomains IB, IIA of HSA and minor groove of DNA.
Ali K; Abul Qais F; Dwivedi S; Abdel-Salam EM; Ansari SM; Saquib Q; Faisal M; Al-Khedhairy AA; Al-Shaeri M; Musarrat J
J Biomol Struct Dyn; 2018 Aug; 36(10):2530-2542. PubMed ID: 28753123
[TBL] [Abstract][Full Text] [Related]
20. A novel prototype of albumin nanoparticles fabricated by supramolecular cyclodextrin-adamantane association.
Lee S; Lee C; Kim B; Thao LQ; Lee ES; Kim JO; Oh KT; Choi HG; Youn YS
Colloids Surf B Biointerfaces; 2016 Nov; 147():281-290. PubMed ID: 27522557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
